Combined TNF-α -308 (rs1800629) genotype and TyG index for identifying metabolic syndrome in a Vietnamese adult cohort

Nguyen Huu Ngoc Tuan, Nguyen Minh Ha

Nội dung chính của bài viết

Tóm tắt

The triglyceride-glucose (TyG) index is a robust surrogate for insulin resistance. This study evaluated the diagnostic and discriminative utility of combining the TyG index with the TNF-α -308G>A (rs1800629) genotype for early identification of Metabolic Syndrome (MetS) in a Vietnamese cohort, accounting for Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD). This cross-sectional analysis included 311 medical and administrative staff. MetS was defined by harmonized criteria. The TyG index and TNF-α -308 genotypes were analyzed using multivariable logistic regression and Area Under the Receiver Operating Characteristic (AUC-ROC) curves, with stratification by MAFLD status. MetS prevalence was 17.4%. The TyG index was a highly significant independent discriminator of MetS (Adjusted OR = 59.73, p < 0.001). The TNF-α -308 A-allele carrier status did not significantly associate with MetS (Adjusted OR = 0.26, p = 0.120). The combined model yielded an AUC of 0.955 versus 0.952 for the reference model (ΔAUC = +0.003). While incremental AUC was slightly higher in the MAFLD subgroup (ΔAUC = +0.014), the synergistic effect was not statistically significant. The TyG index demonstrates excellent diagnostic utility for MetS. However, incorporating the TNF-α -308 genotype does not provide clinically meaningful incremental discriminative value in this population.

Chi tiết bài viết

Tài liệu tham khảo

1. Mostafa AM, Pan Z, Yu M, Örmeci N, Fouad Y, Eslam M. MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk. Hepatic Medicine: Evidence and Research. 2025; 17: 315-340. doi:10.2147/HMER.S506402.
2. Habibullah M, Jemmieh K, Ouda A, Haider MZ, Malki MI, Elzouki AN. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Front Med (Lausanne). 2024; 11:1291501. doi:10.3389/fmed.2024.1291501.
3. Avagimyan A, Pogosova N, Fogacci F, et al. Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. Int J Cardiol. 2025; 418: 132663. doi:https://doi.org/10.1016/j.ijcard.2024.132663.
4. Wan H, Cao H, Ning P. Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis. Sci Rep. 2024; 14(1): 15499. doi:10.1038/s41598-024-66692-9.
5. Dwi Astarini F, Ratnasari N, Wasityastuti W. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iran Biomed J. 2022; 26(4): 252-268. doi:10.52547/ibj.3647.
6. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997; 94(7): 3195-3199. doi:10.1073/pnas.94.7.3195.
7. Ghareeb D, Abdelazem AS, Hussein EM, Al-Karamany AS. Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome. J Diabetes Metab Disord. 2022; 21(2): 1197-1203. doi:10.1007/s40200-022-01059-z.
8. Hamedi-Shahraki S, Klisic A, Amirkhizi F, Mercantepe F. Association of the triglyceride-glucose index with inflammatory markers and dysregulation of adipokines in patients with metabolic syndrome. BMC Endocr Disord. 2026; 26(1): 44. doi:10.1186/s12902-025-02142-5.
9. D’Elia L, Masulli M, Barbato A, et al. Triglyceride-Glucose Index, HOMA Index and metabolic syndrome in a sample of adult men. Minerva Endocrinol (Torino). 2024; 49(3): 349-356. doi:10.23736/S2724-6507.24.04240-2.
10. Taha O, Abdallah L, Erfan A, Elsharaby R, El Amrousy D. The triglyceride glucose index as a biomarker for different glucose disorders in overweight and obese children and adolescents. Eur J Pediatr. 2025; 184(2): 118. doi:10.1007/s00431-024-05940-0.
11. Wang D, He L, Zhang X. -308G/A polymorphism of tumor necrosis factor alpha (TNF-α) gene and metabolic syndrome susceptibility: a meta-analysis. Sci Rep. 2021; 11(1): 3840. doi:10.1038/s41598-021-83321-x.
12. Nguyen H, Le D, Ho T, et al. TNF-α rs1800629 Polymorphism in Vietnamese COPD Patients: Exploratory Evidence for Recessive Protective Association and Clinical Correlates. Appl Clin Genet. 2026; 19: 55-70. doi:10.2147/TACG.S586977.
13. Zhang X, et al. Triglyceride-glucose index demonstrates false-positive association with cardiometabolic multimorbidity progression. Medicine. 2026; 105(7): e41567.